DiaMedica Therapeutics vs Juno Therapeutics
DiaMedica Therapeutics vs Juno Therapeutics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: DiaMedica Therapeutics is on 35/100 and Juno Therapeutics on 66/100.
Where each one leads
DiaMedica Therapeutics
Leads on none of the measures we hold for both companies.
Juno Therapeutics
- our overall score: 66/100 against 35/100
- funding raised: $317M against $30.1M
At a glance
| Measure | DiaMedica Therapeutics | Juno Therapeutics |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases. | Biotechnology company focused on developing cancer immunotherapies. |
| Category | Biotechnology, Healthcare, Pharmaceuticals | Biotechnology, Pharmaceuticals, Cancer Immunotherapy, Cart |
| Sells toBusiness model | B2B | B2B |
| Offering | Biopharmaceutical | Services |
| Founded | 2000 | 2013 |
| Headquarters | Minneapolis, United States | Seattle, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | DiaMedica Therapeutics | Juno Therapeutics |
|---|---|---|
| Total funding | $30.1M | $317M |
| Latest round | Private Placement | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | DiaMedica Therapeutics | Juno Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 35/100 | 66/100 |
| Traction | 37/100 | 40/100 |
| Team | Not published | 90/100 |
| Community | Not published | 15/100 |
| Search visibility | 11/100 | 15/100 |
| Quality | 45/100 | 87/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | Not published |
| Domain ratingLink authority, 0-100 | 34/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | DiaMedica Therapeutics | Juno Therapeutics |
|---|---|---|
| Hosting | AWS | Not detected |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Not detected |
DiaMedica Therapeutics vs Juno Therapeutics: common questions
Which is better, DiaMedica Therapeutics or Juno Therapeutics?
On our 0-100 score Juno Therapeutics rates higher (66/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do DiaMedica Therapeutics and Juno Therapeutics compare on the numbers?
Juno Therapeutics leads on our overall score (66/100 against 35/100), funding raised ($317M against $30.1M).
Read the full DiaMedica Therapeutics review and pricing or the Juno Therapeutics review and pricing. You can also browse other DiaMedica Therapeutics alternatives we track.